Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Resonance Health Ltd ( (AU:RHT) ).
Resonance Health Ltd has notified the ASX of the appointment of Michael Sistenich as a director effective 28 April 2026, in line with the exchange’s requirements for initial directors’ interest notices. The filing confirms that Sistenich currently holds no ordinary fully paid shares in Resonance Health, has no indirect interests in its securities, and has no interests in any related contracts, signalling that he joins the board without an equity stake at the time of appointment.
More about Resonance Health Ltd
Resonance Health Ltd is a listed company on the ASX, but the announcement provides no information about its industry, products, services, or market focus. The disclosure instead focuses solely on corporate governance and director interests in company securities, as required under Australian listing rules.
Average Trading Volume: 371,533
Technical Sentiment Signal: Sell
Current Market Cap: A$20.99M
For a thorough assessment of RHT stock, go to TipRanks’ Stock Analysis page.